Creation of de novo cryptic splicing for ALS/FTD precision medicine

Oscar G. Wilkins(The Francis Crick Institute), Pietro Fratta(MRC Prion Unit)
bioRxiv (Cold Spring Harbor Laboratory)
November 15, 2023
10.1101/2023.11.15.565967
Cited by 5

Related Papers

TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A
|Nature|2022|510
Cell environment shapes TDP-43 function with implications in neuronal and muscle disease
|Communications Biology|2022|52
Creation of de novo cryptic splicing for ALS and FTD precision medicine
|Science|2024|30